跳至主要内容
临床试验/ITMCTR2100005088
ITMCTR2100005088尚未招募未知

A randomized controlled trial evaluating the jiangniaosuan formulation as a treatment for hyperuricemic nephropathy at CKD stages 3-4 patients

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Meet the diagnostic criteria for uric acid nephropathy and TCM syndromes;
  • 2. Age 18-75 years old, with independent behavior ability, no gender limitation;
  • 3. Glomerular filtration rate: 15ml/min<=eGFRCKD-EPI-ASIA<60ml/min;
  • 4. No renal replacement therapy;
  • 5. Sign the informed consent to enter the clinical research.

排除标准

  • 1. Those with allergies or allergic constitution to the test drugs and control drugs;
  • 2. Pregnant or lactating female patients;
  • 3. Patients with abnormal liver function (ALT or AST exceeds the upper limit of normal by 2 times or more);
  • 4. Combined with serious primary diseases such as nervous, cardiovascular, digestive, urinary, endocrine and hematopoietic systems, mental patients;
  • 5. Those who are participating in other clinical drug trials;
  • 6. Those who have received similar treatment within 2 weeks before the trial;
  • 7. Patients with uric acid nephropathy with proteinuria (proteinuria>1g/d) or diabetes or hereditary kidney disease.

研究者

发起方
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验